Instead, I'm going to write about what happened early last December, while I was contemplating a long, cold month of depression following a break-up.
At a willingness to pay threshold of US$ 1,800 (€ 1,500) per prevented month of depression, the probability that the intervention is cost-effective was reported to be 70%.
Mental disorders are among the conditions causing the greatest burden on human health, with estimates in developed countries of the 12 month prevalence of depression alone ranging between 3.1% and 10.3%percentt of the general population.
The items assess the presence of the following features over the previous month: feelings of depression, pessimism, irritability, tearfulness, fatigue, sleep problems, loss of interest, loss of appetite, reduced concentration, and loss of enjoyment.
The 1-month prevalence of depression and dysthymic disorders was 17.1%, while the 1-month prevalence of anxiety disorders was 10%.
During a 12-month bout of depression two years ago, running helped where medication couldn't – and for that reason alone I'll always be grateful to it.
Estimating 12-month prevalence of depression, anxiety, and comorbid anxiety/depression in noninstitutionalized adults (age 15 75) in two violence-prone cities.
To investigate the one-month prevalence of depression morbidity and its association with sociodemographic characteristics, health and functional status, and use of health services in community residents aged 60 years and over in Brazil.
In Ireland 12-month prevalence of depression has been reported to be 10.3%.
For comparison, the 1-month prevalence of depression among Finnish young adults (20 24 years of age) was 9.6% [ 47].
The 12-month prevalence of depression has been reported as 4.1%, with a lifetime prevalence of 6.7% [ 5].
